Rachel J. Goldberg

Learn More
Clinicians are regularly faced with decisions regarding disclosure of information to cancer patients. Many of these decisions constitute a dilemma between the physician's paternalistic concern for the patient and the patient's right to know as much as possible. This paper reviews changes in the attitudes of physicians over the last several decades,(More)
6581 Background: Bevacizumab, a recombinant antibody which neutralizes vascular endothelial growth factor (VEGF), has been approved for the treatment of advanced non-small cell lung cancer (NSCLC). Costs of novel anticancer medications such as bevacizumab can be prohibitive for many lung cancer patients. This study sought to determine patients'(More)
In summary, in the collection, analysis, and interpretation of study data, individuals planning and analyzing the results of their own investigations or those of others must be particularly careful about the potential pitfalls that may occur. Considerable time and effort beforehand should be given to the type of study design (observational versus randomized(More)
  • 1